Glivec Phase II Pediatric Study
Clinical trial NCT00180830 · TERMINATED
Trial details
- NCT number
- NCT00180830
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.